Growth inhibition of breast cancer cells induced by vitamin E succinate combined with tamoxifen

Jun-chu ZHANG,Wei ZHANG,Xin-yun XU,Da-qiao ZHU,Ling-zhen ZHANG,Qiang WANG

DOI: https://doi.org/10.3969/j.issn.1673-5269.2005.16.008

2005-01-01

Abstract:OBJECTIVE:To investigate the inhibitory effect of vitamin E succinate combined with tamoxifen on the proliferation of human breast cancer cells.METHODS: Human breast cancer cells were treated with VES combined with tamoxifen for 24 h and 48 h.The concentrations of VES were 10 μg/mL and 20 μg/mL and those of tamoxifen were 1 μmol/L,5 μmol/L and 10 μmol/L.The inhibitory effect was measured with MTT.Then the cell cycle and cell surface Fas/FasL expression were analyzed with flow cytometry.RESULTS: The co-administration of VES and tamoxifen had significant inhibitory effect on the growth of MCF-7(ER positive) and MDA-MB-435(ER negative) human breast cancer cells.The percentage of G0/G1 phase cells increased and the apoptotic rate rose from 3.30%±0.2% to 25.61%±2.7% and from 4.88%±0.9% to 23.33%±1.1% respectively after the co-administration of VES and tamoxifen.Cell surface Fas expression in cancer cells increased from 50.07 and 46.29 to 116.72 and 136.68 while FasL from 51.85 and 57.43 to 146.82 and 127.90 after treated with VES combined with tamoxifen.CONCLUSIONS: VES combined with tamoxifen has significant inhibitory effect on the growth of human breast cancer cells.The mechanism maybe relates to Fas and FasL upregulation on the surface of cancer cells.